Zobrazeno 1 - 10
of 160
pro vyhledávání: '"C, Naltet"'
Autor:
Francesco Facchinetti, Antonin Levy, Pernelle Lavaud, David Planchard, Samy Ammari, Benjamin Besse, C. Naltet, D. Vasseur, Mihaela Aldea
Publikováno v:
Cancer Management and Research
Background ROS1 tyrosine kinase inhibitors (TKIs) have showed activity and efficacy in ROS1-rearranged non-small cell lung cancer (NSCLC). In the clinical practice, besides the utilization of crizotinib, less is known about the best treatment strateg
Autor:
Pauline Pradere, Etienne Rouleau, Benjamin Besse, Caroline Caramella, Mariona Riudavets, C. Naltet, Cécile Le Péchoux, Julien Adam, Laurence Mabille, David Planchard
Publikováno v:
Clinical Lung Cancer. 22:e215-e219
Publikováno v:
Revue des Maladies Respiratoires Actualités. 15:32
Autor:
F.G. Dall'Olio, L. Mabille, C.A. Garcia, J. Adam, M.R. Ghigna, N. Cozic, C. Caramella, N. Chaput-Gras, D. Planchard, L. Mezquita, J. Remon Masip, P. Lavaud, C. Naltet, A. Gazzah, V. Thomas De Montpreville, O. Mercier, F. Barlesi, B. Besse
Publikováno v:
Annals of Oncology. 33:S977-S978
Autor:
J. Goldman, A. Martínez Bueno, C. Dooms, K. Jhaveri, M.J. de Miguel, S.A. Piha-Paul, N. Unni, A. Mahipal, J.M. Suga, C. Naltet, A. Zick, M. Antoñanzas Basa, J. Crown, Y.K. Chae, D. DiPrimeo, L.D. Eli, L. McCulloch, D. Mahalingam
Publikováno v:
European Journal of Cancer. 174:S82
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ludovic Lacroix, Benjamin Besse, Michèle Beau-Faller, Pamela Biondani, Lizza E.L. Hendriks, Pernelle Lavaud, Julien Adam, Anas Gazzah, Charlotte Leduc, Jordi Remon, Emilie Le Rhun, Ronan Flippot, Caroline Caramella, C. Naltet, David Planchard, Radj Gervais, Cécile Le Péchoux, Laura Mezquita, Dingyu Xiao, Edouard Auclin
Publikováno v:
Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Journal of Thoracic Oncology, 14(8), 1400-1407. Elsevier Science
Journal of Thoracic Oncology, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Journal of Thoracic Oncology, 14(8), 1400-1407. Elsevier Science
Journal of Thoracic Oncology, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Introduction: Leptomeningeal metastases (LMs) are associated with dismal prognosis in NSCLC. Optimal management remains unknown in patients with EGFR-mutated NSCLC after initial tyrosine kinase inhibitor (TKI) failure.Methods: We conducted a multicen
Autor:
L. Mezquita, M. Riudavets, M. Garcia de Herreros, E. Auclin, M. Dorta, V. Albarran, M. Aldea, C. Naltet, M. Grecea, P. Martin-Romano, L.L. Lacroix, C. Nicotra, A. Arcocha, A. Gazzah, C. Pipinikas, C. Morris, K. Howarth, C. Teixidó, R. Reyes, N. Viñolas, C. Massard, F. Barlesi, D. Planchard, B. Besse
Publikováno v:
Journal of Thoracic Oncology. 17:S127
Autor:
C. Naltet, Benjamin Besse
Publikováno v:
Transl Lung Cancer Res
This article is a review of the literature concerning efficacy and safety of immune checkpoint inhibitors (ICIs) in the elderly population. In the past decade, immunotherapy deeply changed the treatment paradigm of lung cancer in particular in advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0337cf660997305194e9f94262ca050d
https://europepmc.org/articles/PMC8264351/
https://europepmc.org/articles/PMC8264351/
Autor:
Fabrice Barlesi, David Planchard, Vincent Ribrag, Jose Carlos Benitez, Y. Loriot, Luc Friboulet, C. Naltet, Veronique Vergé, F.G. Dall'Olio, Pamela Abdayem, Benjamin Besse, J-C. Soria, Cyril Quivoron, Mihaela Aldea, Helene Lecourt, M.R. Ghigna, Pernelle Lavaud, S. de Botton, C. Parisi, F. Blanc-Durand
Publikováno v:
Annals of Oncology. 32:S956-S957